UBS declares quarterly coupon payments on Exchange Traded Note: AMUB

Rhea-AI Summary

UBS Investment Bank has announced quarterly coupon payments for the ETRACS Alerian MLP Index ETN Series B (NYSE Arca: AMUB). The ETN, traded on the NYSE Arca, will distribute a coupon amount of $0.2794 per note. Key dates for this distribution include:

- Coupon Valuation Date: August 15, 2024
- Ex-Date and Record Date: August 28, 2024
- Payment Date: September 6, 2024

The current yield, annualized based on this coupon payment, is 6.30%. However, UBS emphasizes that this yield is not indicative of future coupon payments, and there is no guarantee of any coupon or distribution amount under the ETN.

Positive

• Quarterly coupon payment of $0.2794 per note announced
• Current annualized yield of 6.30% based on the latest coupon payment

Negative

• No guarantee of future coupon payments or distribution amounts

NEW YORK--(BUSINESS WIRE)-- UBS Investment Bank today announced coupon payments for the ETRACS Alerian MLP Index ETN Series B (NYSE Arca: “AMUB”), traded on the NYSE Arca.

NYSE Ticker	ETN Name and Prospectus Supplement*	Coupon Valuation Date	Ex- Date	Record Date	Payment Date	Coupon Amount	Payment Schedule	Current Yield (annualized)**
AMUB	ETRACS Alerian MLP Index ETN Series B	08/15/24	08/28/24	08/28/24	09/06/24	$0.2794	Quarterly	6.30%

* The table above provides a hyperlink to the relevant prospectus and supplements thereto. For more information on the ETRACS ETN, see “List of ETNs”.

**"Current Yield (annualized)" equals the current Coupon Amount, multiplied by four (to annualize such coupon), divided by the Closing Indicative Value of the ETN on its current Coupon Valuation Date rounded to two decimal places for ease of analysis. The Current Yield is not indicative of future coupon payments, if any, on the ETN. You are not guaranteed any coupon or distribution amount under the ETN.

About ETRACS

ETRACS ETNs are senior unsecured notes issued by UBS AG, are traded on NYSE Arca, and can be bought and sold through a broker or financial advisor. An investment in ETRACS ETNs is subject to a number of risks, including the risk of loss of some or all of the investor’s principal, and is subject to the creditworthiness of UBS AG. Investors are not guaranteed any coupon or distribution amount under the ETNs. We urge you to read the more detailed explanation of risks described under “Risk Factors” in the applicable prospectus supplement for the ETRACS ETN.

UBS AG has filed a registration statement (including a prospectus and supplements thereto) with the Securities and Exchange Commission, or SEC, for the offerings of securities to which this communication relates. Before you invest, you should read the prospectus, along with the applicable prospectus supplement to understand fully the terms of the securities and other considerations that are important in making a decision about investing in the ETRACS. The applicable offering document for the ETRACS ETN may be obtained by clicking on the name of the ETRACS ETN identified above. You may also get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. The securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.

About UBS

UBS is a leading and truly global wealth manager and the leading universal bank in Switzerland. It also provides diversified asset management solutions and focused investment banking capabilities. With the acquisition of Credit Suisse, UBS manages 5.7 trillion dollars of invested assets as per fourth quarter 2023. UBS helps clients achieve their financial goals through personalized advice, solutions and products. Headquartered in Zurich, Switzerland, the firm is operating in more than 50 markets around the globe. UBS Group shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).

This material is issued by UBS AG and/or any of its subsidiaries and/or any of its affiliates ("UBS"). Products and services mentioned in this material may not be available for residents of certain jurisdictions. Past performance is not necessarily indicative of future results. Please consult the restrictions relating to the product or service in question for further information. Activities with respect to US securities are conducted through UBS Securities LLC, a US broker/dealer. Member of SIPC (http://www.sipc.org/).

ETRACS ETNs are sold only in conjunction with the relevant offering materials. UBS has filed a registration statement (including a prospectus, as supplemented by the applicable prospectus supplement for the offering of the ETRACS ETNs) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read these documents and any other documents that UBS has filed with the SEC for more complete information about UBS and the offering to which this communication relates. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, you can request the applicable prospectus and prospectus supplement by calling toll-free (+1-877-387 2275). In the US, securities underwriting, trading and brokerage activities and M&A advisor activities are provided by UBS Securities LLC, a registered broker/dealer that is a wholly owned subsidiary of UBS AG, a member of the New York Stock Exchange and other principal exchanges, and a member of SIPC. UBS Financial Services Inc. is a registered broker/dealer and affiliate of UBS Securities LLC.

UBS specifically prohibits the redistribution or reproduction of this communication in whole or in part without the prior written permission of UBS and UBS accepts no liability whatsoever for the actions of third parties in this respect.

Alerian MLP Index and AMZ are trademarks of Alerian and their use is granted under a license from Alerian.

© UBS 2024. The key symbol, UBS and ETRACS are among the registered and unregistered trademarks of UBS. Other marks may be trademarks of their respective owners. All rights reserved.

¹ Individual investors should instruct their broker/advisor/custodian to call us or should call together with their broker/advisor/custodian.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240821691949/en/

Media contact

Alison Keunen

+1-212-713-2296

alison.keunen@ubs.com



Institutional Investor contact¹

+1-877-387 2275

Source: UBS

FAQ

What is the coupon amount for UBS's ETRACS Alerian MLP Index ETN Series B (AMUB)?

The coupon amount for UBS's ETRACS Alerian MLP Index ETN Series B (AMUB) is $0.2794 per note.

When is the payment date for the AMUB ETN coupon announced by UBS?

The payment date for the AMUB ETN coupon announced by UBS is September 6, 2024.

What is the current annualized yield for UBS's AMUB ETN based on the latest coupon payment?

The current annualized yield for UBS's AMUB ETN based on the latest coupon payment is 6.30%.

Are future coupon payments guaranteed for UBS's ETRACS Alerian MLP Index ETN Series B (AMUB)?

No, future coupon payments are not guaranteed for UBS's ETRACS Alerian MLP Index ETN Series B (AMUB). The announcement states that investors are not guaranteed any coupon or distribution amount under the ETN.